#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Extra-osseous Ewing's sarcoma recurrent Metastatic gastric cancer Atypical haemolytic uraemic syndrome Glomerulonephritis Neuromyelitis optica spectrum disorder Kawasaki's disease B-cell small lymphocytic lymphoma Metachromatic leukodystrophy Complex regional pain syndrome Sickle cell disease Splenic marginal zone lymphoma Glioblastoma Angiosarcoma recurrent Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Rett syndrome – Life with Disease Turner’s syndrome – Diagnostics Antisynthetase syndrome – Basic Information Hairy cell leukaemia – Trials in Disease Aicardi-Goutieres syndrome – Basic Information Noonan syndrome – Treatment Pituitary-dependent Cushing’s syndrome Synovial sarcoma metastatic – Treatment Factor VIII deficiency – Treatment Gaucher’s disease type III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Glutamic Acid Alclometasone Dipropionate Mk-2060 F510/08 Finasteride STREPTOCOCCUS PYOGENES Doconexent Resiquimod Sulfate Bidridistrogene Xeboparvovec Nicotine Glipizide GAXILOSE ARFOLITIXORIN Spiramycin Rp-1664 Sulfate Clioquinol IHMA-2121771-2 Calcium Clopidogrel Acoramidis Hydrochloride More therapies…

    Learn about Your Condition

    Primary amyloidosis Coma Urticaria chronic Malignant melanoma stage IV Lymphoedema Oesophageal food impaction Coronary artery occlusion Exudative retinopathy Peripheral artery angioplasty Progressive multiple sclerosis Lichen sclerosus Osteomyelitis Perineal injury Malignant peritoneal neoplasm Barrett's oesophagus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mqmfsi Zrjdcqvu Kclil 2ss Dbwzcwmsn 4jikq Hlglble

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Estonia France Germany +12

  • Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Envudeucitinib
    • Apremilast
    Austria Estonia France Germany Hungary Latvia +3

  • Study on the Effects of PF-07976016 and Liraglutide in Adults with Obesity

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Liraglutide
    Hungary Poland

  • Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

    Not recruiting

    3 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Austria Czechia France Germany Hungary Italy +4

  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6

  • Study on the Effectiveness of LY4100511 for Adults with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Ly4100511
    Czechia Germany Hungary Poland

  • Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Norucholic Acid
    Austria Belgium Denmark France Germany Hungary +4

  • Study on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment

    Not recruiting

    2 1
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark France Germany Hungary Italy +4

  • Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10
Previous Page
1 … 26 27 28 29 30 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!